Skip to content
Clinical Trials – home
HungaryBack to Hungary

Clinical trials in Gyor – page 7

149 clinical trials in Gyor, Hungary across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

Gyor at a glance
149
clinical trials
  • Research sites1
Type of trial
Recruitment status
Quick filters

149 trials in Gyor

Open in trial search

Study Comparing DB-1303 and Chemotherapy for Patients with HER2-low, Hormone Receptor Positive, Metastatic Breast Cancer

Registered drugNo placebo
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Capecitabine
  • Sponsor:Dualitybio Inc.

Crohn's disease

Not recruiting

Study on the Long-Term Safety and Efficacy of Oral Ozanimod for Patients with Moderate to Severe Crohn's Disease

InvestigationalNo placebo
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Ozanimod
  • Sponsor:Celgene International II S.a.r.l.
Countries:HungaryHungary
  • Participants:65+ years
  • Substances:Acalabrutinib
  • Sponsor:Acerta Pharma B.V.

Ischaemic stroke+2

Not recruiting

Study on Asundexian for Preventing Ischemic Stroke in Adults After a Stroke or High-Risk Mini-Stroke

Investigational
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Asundexian
  • Sponsor:Bayer AG

Study of tarlatamab and durvalumab compared to durvalumab alone for patients with extensive stage small cell lung cancer

Registered drugNo placebo
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Argipressin
  • Sponsor:Amgen Inc.

Evaluation of Pembrolizumab, Patritumab Deruxtecan, and Drug Combinations in Stage IV Non-Small Cell Lung Cancer: A Phase 2 Umbrella Study

Registered drugNo placebo
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:Merck Sharp & Dohme LLC
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Abemaciclib
  • Sponsor:AstraZeneca AB

Embolism venous

Not recruiting

Comparison of SRSD107 and enoxaparin to prevent blood clots in adults undergoing knee replacement surgery

Registered drug
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Enoxaparin Sodium
  • Sponsor:Sirius Therapeutics Inc.

Multiple sclerosis

Not recruiting

Study on the Effectiveness and Safety of Frexalimab and Teriflunomide for Adults with Relapsing Multiple Sclerosis

Registered drug
Countries:HungaryHungary
  • Participants:18–64 years
  • Sponsor:Sanofi-Aventis Recherche & Developpement

Study Comparing Acasunlimab and Pembrolizumab with Docetaxel for Patients with Metastatic Non-Small Cell Lung Cancer After Previous Treatments

Registered drugNo placebo
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Acasunlimab
  • Sponsor:Genmab A/S

Study on the Effectiveness and Safety of Datopotamab Deruxtecan Compared to Chemotherapy in Adults with Advanced Triple-negative Breast Cancer

Registered drugNo placebo
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Capecitabine
  • Sponsor:AstraZeneca AB

Study of Quizartinib with Chemotherapy for Adults with Newly Diagnosed FLT3-ITD Negative Acute Myeloid Leukemia

Registered drug
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Cytarabine
  • Sponsor:Daiichi Sankyo Inc.

Other cities in Hungary

The busiest research cities in the country

All 71 cities in Hungary

Clinical research in Gyor

What the registry says about research in the country

01 Oncology Research

Innovative clinical trials focusing on multiple cancer types, including breast, lung, and prostate cancer. Studies are evaluating novel combination therapies and immunotherapy approaches.

  • Advanced Breast Cancer Treatments
  • Non-Small Cell Lung Cancer Therapy
  • Prostate Cancer Interventions

Research includes targeted therapies for hormone receptor-positive cancers and new treatment combinations for metastatic disease.

02 Cardiovascular and Renal Studies

Research centered on treating chronic kidney disease and preventing cardiovascular events. Studies evaluating new therapeutic approaches for blood pressure management.

  • Kidney Disease Management
  • Stroke Prevention
  • Atrial Fibrillation Treatment

Focus on innovative combinations of medications to improve patient outcomes in cardiovascular conditions.

03 Immunology and Inflammatory Conditions

Clinical investigations examining treatments for autoimmune disorders and inflammatory conditions, including multiple sclerosis and ulcerative colitis.

  • Multiple Sclerosis Therapies
  • Inflammatory Bowel Disease
  • Immune Thrombocytopenia

Testing novel therapeutic approaches to modify immune response and reduce inflammation.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.